| TS | Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str... |
|---|---|
| TSA | technical surgical assistance; toluene sulfonic acid; total shoulder arthroplasty; total solute abso... |
| TSTA | toxoplasmin skin test antigen; tumor-specific tissue antigen; tumor-specific transplantation antigen... |
| CEA | Carcino-Embryonic Antigen [HP 1825-6] ; Oncofetal Antigens ; Glycopro... |
| DIT | Diet Induced Thermogenesis = Thermic Effect of Food = Specific Dynami... |
| rickettsial vaccines | Vaccines for the prevention of diseases caused by various species of rickettsia. (12 Dec 1998) |
|---|---|
| poliomyelitis vaccines | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| poliovirus vaccines | Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine. See: Salk vaccine. (05 Mar 2000) |
| haemophilus vaccines | Vaccines or candidate vaccines containing antigenic polysaccharides from haemophilus influenzae and designed to prevent infection. The vaccine can contain the polysaccharides alone or more frequently polysaccharides conjugated to carrier molecules. It is also seen as a combined vaccine with diphtheria-tetanus-pertussis vaccine. (12 Dec 1998) |
| saids vaccines | Vaccines or candidate vaccines designed to prevent saids (simian acquired immunodeficiency syndrome) and containing inactivated siv or type d retroviruses or some of their component antigens. (12 Dec 1998) |
| hepatitis b vaccines | Vaccines or candidate vaccines containing inactivated hepatitis b or some of its component antigens and designed to prevent hepatitis b. Some vaccines may be recombinantly produced. (12 Dec 1998) |
| protozoan vaccines | Suspensions of attenuated or killed protozoa administered for the prevention or treatment of infectious protozoan disease. (12 Dec 1998) |
| hog cholera vaccines | Vaccine's either of virus from blood of infected swine, inactivated with crystal violet, or live virus attenuated in rabbits or tissue culture and frequently used in conjunction with hog cholera virus antiserum. (05 Mar 2000) |
| influenza virus vaccines | Influenza virus grown in embryonated eggs and inactivated, usually by the addition of formalin; both whole virus and subunit preparations containing haemagglutinins and neuraminidase are used; because of the marked and progressive antigenic variation of the influenza viruses, the strains included are regularly changed following various outbreaks of influenza in order to include most recently isolated epidemic strains of both type A influenza and type B influenza. (05 Mar 2000) |
| foot-and-mouth disease virus vaccines | Vaccine's either of inactivated virus from infected cattle tongue epithelium or, more recently, of live virus attenuated by embryonated egg or mouse passage and propagated in tissue culture. (05 Mar 2000) |
| fungal vaccines | Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease. (12 Dec 1998) |
| live vaccines | Vaccines containing living organisms or intact viruses. (14 Nov 1997) |
| age-specific rate | A rate for a specified age group, in which the numerator and denominator refer to the same age group. (05 Mar 2000) |
| Bensley's specific granules | Granule's in the cells of the islands of Langerhans in the pancreas. (05 Mar 2000) |
| brain-specific kinase | <enzyme> Expressed specifically in brain; member of the eph/elk receptor-like kinase family; mw 105 kD; may represent murine homolog of chicken cek7 receptor-like kinase; amino acid sequence given in first source Registry number: EC 2.7.1.- Synonym: bsk tyrosine kinase (26 Jun 1999) |